PARSIPPANY, N.J., April 23, 2024 (Globe Newswire) — Envector Corporation (“Envector”) (Nasdaq: EMBC), a global diabetes care company with a 100-year heritage in insulin delivery, Host a conference call to discuss. On Thursday, May 9, 2024 at 8 a.m. Eastern Time (ET), we will present our second quarter fiscal 2024 financial results, provide an operational update, and host a question-and-answer session.
If you would like to participate, please access the live webcast here or the conference call here. The live webcast can also be accessed through the company's website at investors.embecta.com.
A replay of the conference call webcast will be available for viewing via the embecta Investor Relations website beginning May 9, 2024 at 11:00 a.m. ET and will be archived on the website for one year.
About envectors
embecta is a global diabetes care company that leverages a 100-year heritage in insulin delivery to help people with diabetes live their best lives through innovative solutions, partnerships and the passion of more than 2,000 employees worldwide. It's a company. For more information, visit emecta.com or follow us on our social channels on LinkedIn, Facebook, Instagram, and Twitter.
contact address:
|
media |
Investor |
|
Christian Glasal |
Pravesh Khandelwal |
|
Senior Director of Corporate Communications |
Vice President, Head of Investor Relations |
|
908-821-6922 |
551-264-6547 |
|
Media inquiries |
Inquiries to IR |
